|
|
| Balance Sheet |
|
| ERIS Lifesciences Ltd | | Industry : Pharmaceuticals - Indian - Formulations | Chairman : Amit Indubhushan Bakshi | | Home : Indian Private | Book Value: 180.2356794 | | BSE Code : 540596 | Market Cap: 11796 | | NSE Code : ERIS | P / E : 33.9 | |
| |
|
|
|
| (Rs in Cr.) |
 |
 |
| SOURCES OF FUNDS: | | | Share Capital | 13.60 | 13.59 | 13.58 | 13.58 | 13.75 | | Reserves & Surplus | 2208.29 | 1904.96 | 1561.89 | 1286.12 | 1142.26 | | Total Shareholders Funds | 2221.89 | 1918.55 | 1575.47 | 1299.70 | 1156.01 | | Secured Loans | 264.47 | 0.00 | 0.00 | 0.00 | 175.92 | | Unsecured Loans | 120.93 | 65.62 | 34.88 | 33.99 | 23.73 | | Total Debt | 385.40 | 65.62 | 34.88 | 33.99 | 199.65 | | Total Liabilities | 2607.29 | 1984.17 | 1610.35 | 1333.69 | 1355.66 | | APPLICATION OF FUNDS: | | Gross Block | 1089.83 | 778.40 | 716.88 | 695.65 | 551.81 | | Less: Accum. Depreciation | 192.02 | 136.40 | 132.55 | 95.01 | 67.96 | | Net Block | 897.81 | 642.00 | 584.33 | 600.64 | 483.85 | | Capital Work in Progress | 0.34 | 2.98 | 1.56 | 4.37 | 2.73 | | Investments | 996.52 | 777.72 | 531.37 | 320.30 | 580.47 | | Inventories | 63.70 | 84.79 | 64.85 | 65.46 | 74.70 | | Sundry Debtors | 229.22 | 137.56 | 113.76 | 140.82 | 75.90 | | Cash and Bank Balance | 47.65 | 46.11 | 32.66 | 64.95 | 6.47 | | Loans and Advances | 673.77 | 573.85 | 526.82 | 363.04 | 304.76 | | Current Liabilities | 239.46 | 237.97 | 210.60 | 190.80 | 152.56 | | Provisions | 62.27 | 42.86 | 34.38 | 35.10 | 20.68 | | Net Current Assets | 712.61 | 561.48 | 493.11 | 408.37 | 288.59 | | Miscellaneous Expenses not w/o | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Total Assets | 2607.28 | 1984.18 | 1610.37 | 1333.68 | 1355.64 | | Contingent Liabilities | 25.39 | 24.34 | 18.32 | 15.81 | 15.29 |
|
|
|
|
|